OGEN News and Press, Oragenics Inc. From 10/18/23

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced the appointments of Bruce Cassidy and John Gandolfo to the Board of Directors effective October 4, 2023. “We are delighted to welcome Bruce Cassidy and John Gandolfo to the Oragen...

2023-10-05 10:00:20 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Citi turns cautious on pharmaceuticals and biotech For further details see: Orchard Therapeutics, Longeveron among healthcare movers

2023-10-05 06:51:17 ET More on Oragenics Oragenics and Lantern Bioworks enter into a partnership Oragenics announces private placement Financial information for Oragenics For further details see: Oragenics to acquire certain assets of Odyssey Health

Gains Nasal Delivery Technologies and Expands Product Pipeline Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) and Odyssey Health, Inc. (OTCQB: ODYY ) (“Odyssey”) announce the signing of a definitive agreement under wh...

2023-10-02 10:00:06 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

2023-10-02 08:25:27 ET Bionomics  ( NASDAQ: BNOX ) +21% . Femasys  ( FEMY ) +18% . Lead Real Estate  ( LRE ) +14% . Acurx Pharmaceuticals ( ACXP ) +16% Announces Successful Completion and Early Discontinuation of the Ibezapo...

2023-09-29 16:21:17 ET More on Oragenics Oragenics announces private placement Financial information for Oragenics For further details see: Oragenics and Lantern Bioworks enter into a partnership

Potential to Protect Against Dental Caries, a Global Health Issue Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) and Lantern Bioworks announce a groundbreaking partnership, marked by the formalization of a materials transfer agreement....

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), biotech company dedicated to fighting infectious diseases including coronaviruses, today announced it has entered into definitive agreements with two healthcare-focused investors, in which the Comp...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases, announces the award of a grant from CQDM, a Canadian bioresearch consortium, for the collaborative development of a variant-agnost...